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Deletion of serine 63 from P0 glycoprotein (P0S63del)
causes Charcot-Marie-Tooth 1B neuropathy in hu-
mans,andP0S63del producesa similar demyelinating
neuropathy in transgenic mice. P0S63del is retained in
the endoplasmic reticulum and fails to be incorpo-
rated into myelin. Here we report that P0S63del is mis-
folded and Schwann cells mount a consequential
canonical unfolded protein response (UPR), including
expression of the transcription factor CHOP, previ-
ously associated with apoptosis in ER-stressed cells.
UPR activation and CHOP expression respond dy-
namically to P0S63del levels and are reversible but
are associated with only limited apoptosisof Schwann
cells. Nonetheless, Chop ablation in S63del mice
completely rescues their motor deficit and reduces
active demyelination 2-fold. This indicates that signal-
ing through the CHOP arm of the UPR provokes demy-
elination in inherited neuropathy. S63del mice also
provide an opportunity to explore how cells can dys-
function yet survive in prolonged ER stress—impor-
tant for neurodegeneration related to misfolded
proteins.
INTRODUCTION
Myelin protein zero (P0) is the major protein produced by myeli-
nating Schwann cells (Kirschner et al., 2004). P0 is a single-pass
transmembrane protein, with a large amino-terminal extracellu-
lar domain (ECD) and a short carboxy-terminal intracellular tail.
The protein is encoded by the Mpz gene and synthesized in
the endoplasmic reticulum (ER), where it undergoes N-glycosyl-
ation and formation of one intramolecular disulfide bond. In
myelin, P0 is present as tetramers that compact the extracellular
appositions of myelin wraps via in trans homophilic interactions
(D’Urso et al., 1990; Filbin et al., 1990; Shapiro et al., 1996).
Accordingly, mice with homozygous disruption of Mpz showuncompaction of myelin in development (Giese et al., 1992),
and mice with heterozygous disruption show altered myelin
maintenance in the adult (Martini et al., 1995).
More than 100 mutations of P0, many in the ECD, are associ-
ated with hereditary motor and sensory neuropathies (Shy, 2005;
Wrabetz et al., 2004). Although the specific pathogenetic mech-
anisms have not been fully elucidated, dominant inheritance and
widely varying phenotypes suggest that many P0 mutations act
through gain of abnormal function (Martini et al., 1995; Wrabetz
et al., 2006). For example, deletion of serine 63 (S63del) or its
mutation to a cysteine (S63C) results in Charcot-Marie-Tooth
(CMT) type 1B and De`je`rine-So`ttas syndrome (DSS) in humans,
respectively (Hayasaka et al., 1993; Kulkens et al., 1993). Trans-
genic mice expressing both mutant and normal P0 confirm that
these mutations produce a gain of abnormal function (Wrabetz
et al., 2006). The pathomechanisms are likely to differ between
the twomutations, for although S63C is incorporated intomyelin,
producing packing defects, S63del is retained in the ER.
In the ER, membrane proteins are subject to stringent quality
control (Ron and Walter, 2007). Accumulation of misfolded pro-
teins in the ER sequesters chaperones like binding immunoglob-
ulin protein (BiP) and activates the unfolded protein response
(UPR). As an adaptive response, UPR upregulates transcription
of chaperones, temporarily attenuates new translation, and acti-
vates protein degradation via the proteasome. However, at high
levels of ER stress, UPR signaling contributes to apoptosis (Ron
and Walter, 2007). For example, deletion of the gene encoding
CHOP (CAATT enhancer-binding protein homologous protein,
a transcription factor active in the UPR) protects cells against
apoptosis (Marciniak et al., 2004; Zinszner et al., 1998).
Here we report that P0S63del activates a canonical and dose-
dependent UPR, including CHOP, and consequentially, demye-
lination in Schwann cells. ER retention and UPR depend on alter-
ation of the pattern of hydrophobic residues in P0 b strand C, not
changes at residue 63, a mechanism potentially shared by an-
other CMT1B mutation, deletion of phenylalanine 64 (Ikegami
et al., 1996). Ablation of Chop in S63del mice reverses behav-
ioral, electrophysiological, and morphological abnormalities, in-
dicating the UPR as a novel pathogenetic mechanism in demye-
linating peripheral neuropathies. Finally, UPR activation is rapidlyNeuron 57, 393–405, February 7, 2008 ª2008 Elsevier Inc. 393
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UPR Modulates CMT1B NeuropathyFigure 1. P0S63del Is Retained in the ER
and Induces a Dose-Dependent UPR
(A) Immunofluorescence analysis for P0 or KDEL
on teased fibers shows that P0 staining is aug-
mented in the ER of myelinating Schwann cells
from P0S63del (arrows), as compared to WT (ar-
rowheads), sciatic nerves.
(B and C) BiP and CHOP mRNA levels were mea-
sured in P28 sciatic nerves by quantitative RT-
PCR and normalized to 18S rRNA, WT = 1. L,
low, H, high expressor S63del transgenes; OE,
P0 wild-type overexpressor; tun, tunicamycin;
error bars, SEM for n = individual nerves from
3–5 animals. *p < 0.001, **p < 0.05 relative to WT
by Student’s t test.
(D) Western analysis for BiP and CHOP was per-
formed on freshly dissected nerves or WT nerve
segments cultured overnight with tunicamycin or
sham media. Note that CHOP, but not BiP,
mRNA and protein levels parallel the ratio of
P0S63del (arrowhead) to P0wt (arrow) and the se-
verity of neuropathy (Wrabetz et al., 2006) in
S63del mice. Calnexin (CNX) levels do not change.
BiP and CHOP are induced upon tunicamycin
treatment of WT nerve (wt/Tun +). b-Tubulin (Tub)
provides a control for loading.
(E) DOC1, 6, and 4 mRNA levels are induced by
tunicamycin treatment of NIH 3T3 cells (note the
logarithmic scale), but only DOC1 and 6 are in-
duced in S63del nerves. DOC4 is not induced
even by tunicamycin treatment of nerve.reversed by reducing mutant protein levels in mutant nerves,
suggesting its dosage as a logical therapeutic target. Given
that Schwann cell death follows, not precedes demyelination,
we propose that the maladaptive UPR and CHOP in S63del
nerves produces a novel cellular dysfunction in Schwann cells.
RESULTS
Protein Quality Control in S63del Nerves
P0S63del causes a demyelinating neuropathy via gain of abnor-
mal function, but does not arrive to the myelin sheath (Wrabetz
et al., 2006). To characterize potential toxic mechanisms opera-
tive outside of myelin, we surveyed protein quality control in
S63del nerves. We considered autophagy (lysosomes), protea-
somes, and UPR in S63del nerves. LAMP1 staining was slightly
expanded but did not reveal the lysosomal aggregates that have
been reported for PMP22 mutants, where aggresomes are
cleared by autophagy (see Figure S1 available online) (Fortun
et al., 2003). Electron microscopy did not reveal aggregates or
swollen ER (Tsang et al., 2007) in S63del Schwann cells (Fig-
ure S2A). Also, EDEM1, a marker of endoplasmic reticulum acti-
vated degradation (ERAD), was expressed at normal levels, pre-
liminarily suggesting limited ERAD and proteasomal involvement
(Figure S2B).
Whenexpressed inmiceof theMpznull background, P0S63del
is retained in the endoplasmic reticulum (Wrabetz et al., 2006).394 Neuron 57, 393–405, February 7, 2008 ª2008 Elsevier Inc.However, CMT1B patients have both MPZ WT and S63del
alleles. Even when P0S63del was coexpressed with P0wt (Fig-
ure5C), immunostainingon teasedfibers showed thatP0was still
retained in the ER (Figure 1A). These data, taken together with
preliminary evidence that the transcription of BiP and CHOP is
upregulated in S63del nerves (Wrabetz et al., 2006), suggest
that the UPR is an important form of quality control for P0S63del.
Therefore, we asked whether P0S63del elicited a full UPR and
how the UPR correlated with disease. In mouse, disease severity
correlates with MpzS63del mRNA expression (Wrabetz et al.,
2006). Toexaminedosedependence,weexploitedmiceexpress-
ing S63del mRNA at levels of one (S63del-L) or two (S63del-H)
endogenous alleles. BiP and CHOPmRNA levels were increased
by 5.2- and 2.7-fold in S63del-L and 5.7- and 14.6-fold in S63del-
H sciatic nerves, respectively (Figures 1B and 1C). Induction of
BiP and CHOP mRNA was tissue and mutation specific. It was
not detected in the brain (data not shown) or in nerves of S63C,
P0Myc (pathological model of CMT1B; Previtali et al., 2000), or
P0 overexpressormice (Wrabetz et al., 2000; Yin et al., 2000) (Fig-
ure 1B). The level of induction was robust, comparable to the
levels of BiP and CHOP mRNA acutely induced by tunicamycin
(glycosylation inhibitor) in liver (2.5- and 19-fold) (Figures 1B and
1C) or cultured sciatic nerve segments (4- and 10-fold) (Figures
5A and 5B) of normal mice.
Induction of BiP and CHOP in S63del and tunicamycin-treated
nerves was confirmed by western analysis (Figure 1D). As for
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UPR Modulates CMT1B NeuropathyFigure 2. Activation of IRE-1, PERK, and ATF6 Arms of the UPR in S63del Nerves
(A) IRE-1 catalyzes excision of a 26 nt fragment from XBP-1 mRNA. Semiquantitative RT-PCR for XBP-1 unspliced (XBP-1u), spliced (XBP-1 s), normalized to
GAPDH, shows that the spliced XBP-1 is enriched in S63del and tunicamycin-treated nerves. P0wt overexpressor (OE) nerves are included as expression-
matched controls for S63del low (L) and high (H). Error bars, SEM for n = 6 individual nerves, *p < 0.05 relative to WT by Student’s t test.
(B) Levels of eIF2a, eIF2a-P (phosphorylated), and ATF4 were measured by western analysis. Tubulin (Tub) shows equal loading.
(C) ATF3 mRNA was measured by quantitative RT-PCR and normalized to phosphoglycerate kinase 1(PGK1) mRNA. ATF3 is induced in a dose-dependent fash-
ion in S63del mice and in tunicamycin-treated livers. Error bars, SEM, n = 6, 5, 5, 3, and 3 nerves for WT, S63del-L, S63del-H, OE-L, OE-H, respectively, and 3
livers. **p < 0.01, *p< 0.05 relative to WT by Student’s t test.
(D) Immunostaining reveals CHOP in elongated, DAPI-positive Schwann cell nuclei in longitudinal sections of S63del nerves at P28 (b–b00), but is undetectable in
normal nerves (a–a00). Many CHOP-positive Schwann cells contain integral myelin sheaths (c–c00 0 ). Scale bar, 15 mm in a–b00; 13 mm in c–c00 0.
(E) Western analysis for ATF6 reveals dose-dependent cleavage of the 90 kD precursor protein (arrowhead) to the 50 kD product (arrow) only in S63del, not in
S63C, P0 overexpressor (OE), or WT nerves. Numbers indicate relative molecular weights (Mr).mRNA levels, CHOP protein induction was higher in S63del-H
mice than in S63del-L mice, in parallel with the ratio of mutant
P0S63del to P0wt. CHOP activates transcription of the Down-
stream Of CHOP genes (DOCs) (Wang et al., 1998). Accordingly,
DOCs 1 and 6, although not 4, were induced in S63del nerve.
Tunicamycin treatment activated DOC4 in NIH 3T3 cells, but
not in sciatic nerve, raising the possibility that Schwann cells
respond differently to CHOP (Figure 1E). Altogether, these data
show that BiP, CHOP, and its target genes are upregulated
in S63del nerves to levels comparable to those found when
UPR is acutely induced by tunicamycin. Of these, the level of
CHOP correlated best with mutant protein level and disease
severity.IRE-1, PERK, and ATF6 Pathways Are Activated
in S63del Nerves
To characterize the UPR in S63del nerves more fully, we ana-
lyzed activation of the three arms of the UPR: IRE-1 and PERK
kinases and cleavage of ATF6 transcription factor (Ron andWal-
ter, 2007). Activated IRE-1 noncanonically splices the mRNA
of the transcription factor X-box-binding protein 1 (XBP-1), an
event specific to UPR (Yoshida et al., 2001). The spliced form
of XBP-1 was increased by 2.5-, 2.7-, and 5-fold in S63del-L,
S63del-H, and tunicamycin-treated nerves, respectively (Fig-
ure 2A). Activated PERK phosphorylates eIF2a and upregulates
translation of the transcription factor ATF4 and transcription of
ATF3, CHOP, and the oxidoreductin ERO1-Lb (Jiang et al.,Neuron 57, 393–405, February 7, 2008 ª2008 Elsevier Inc. 395
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UPR Modulates CMT1B NeuropathyFigure 3. Alteration of P0 b Strand C Polar-
ity Causes ER Retention and Activation of
the UPR
(A) Western analysis was performed for P0 under
reducing (DTT +) or nonreducing conditions (DTT –)
on peripheral nerve lysates from WT, S63del/
P0/ (S63del), or S63C/P0/ (S63C) mice.
Therefore, in mutant mice, only mutant P0 is
present. Under nonreducing conditions, WT and
mutant P0 show a 3–4 kD shift as expected for
the formation of one disulfide bond. Note that non-
reduced S63del produces a smear (arrowhead)
that might represent protein misfolding. The ma-
jority of P0S63del recognized in this analysis is
unglycosylated (Wrabetz et al., 2006) andmigrates
at a lowerMr. In contrast, S63C produces discrete
bands with the same mobility as P0wt. (B) P0
b strand C is characterized by an alternating hy-
drophilic (black) and hydrophobic (red) pattern of
residues. In contrast to S63C, deletion of either
S63 or F64 or the mutant S63F/T65F and S63F is
predicted to alter the orientation of 4, 3, 2, and 1
hydrophobic residues, respectively. The correla-
tion between number of altered (alt) hydrophobic
residues and ER retention (Ret +) in transfected
cells is shown. COS-7 cells were transfected
with constructs encoding various P0wt- or P0mu-
tant-DsRed fusion proteins and analyzed for ex-
pression of UPR markers (C) or for trafficking of
P0 (D). BiP mRNA was measured by quantitative
RT-PCR and normalized to 18S rRNA for transfec-
tion efficiency. XBP-1 and GAPDHweremeasured
by semiquantitative RT-PCR. Note that BiP mRNA
levels and XBP-1 splicing (XBP-1 s, arrow) are
enriched in cells expressing either P0S63del or
P0F64del mutants, as well as in cells treated with
tunicamycin (a representative experiment [of
three] is shown; error bars, SEM). (D) Confocal
microscopy of trafficking of P0-DsRed fusion
proteins (P0, red) and immunostaining for calnexin
(CNX, green) is shown in overlay. P0wt, P0S63C,
and P0S63F are delivered to the cell membrane,
whereas P0S63del and P0F64del are completely
retained in the ER (yellow signal). P0S63F/T65F
was mostly retained in the ER, although some
was delivered to the plasma membrane in some
cells. Scale bar, 20 mm.2004; Pagani et al., 2000; Ron and Walter, 2007). Indeed, the
levels of eIF2a phosphorylation increased 1.8-fold, and ATF4
3-fold in S63del-L nerves (Figure 2B). Similarly, ATF3 mRNA
was induced 2.5-fold in S63del-L, 12.4-fold in S63del-H nerves,
and 6.1-fold in tunicamycin-treated liver (Figure 2C). Likewise,
ERO1-Lb was induced in S63del-H nerves and tunicamycin-
treated liver to a similar extent (Figure S2C and data not shown).
The UPR was activated in Schwann cells, as the transcription
factor CHOP, which was undetectable in normal nerves, was
localized to the nucleus of S63del Schwann cells (Figure 2D).
Finally, dose-dependent ATF6 cleavage was detected in
S63del-L and -H nerves (Figure 2E). Thus, P0S63del provokes
a dose-dependent activation of IRE-1, PERK, and ATF6
pathways in Schwann cells of S63del nerves, indicating a canon-
ical UPR.396 Neuron 57, 393–405, February 7, 2008 ª2008 Elsevier Inc.Alteration of b Strand C Periodicity
in P0 Causes ER Retention
In S63del nerves, ER retention of P0S63del and UPR activation
suggested proteinmisfolding. Thus, we performedwestern anal-
ysis for the intramolecular disulfide bond of P0 (Figure 3A). The
mobility of P0wt was increased by 3–4 kD under nonreducing
conditions, consistent with the presence of a disulfide bond.
Nonreduced P0S63del showed a similar shift (arrowhead), but
in addition produced a smear, which could represent alterna-
tively folded intermediates. In contrast, another neuropathic mu-
tation at the same residue, P0S63C, which is not retained in the
ER, migrated similarly to P0wt.
Serine 63 lies in b strand C, characterized by an alternating hy-
drophobic and hydrophilic pattern of residues (Figure 3B) (Sha-
piro et al., 1996). We hypothesized that deletion of serine 63
Neuron
UPR Modulates CMT1B Neuropathyaltered the disposition of the 4 hydrophobic residues (FWYP) in
b strand C (Figure 3B, compare WT and S63del). Therefore, we
compared the effect of deleting serine 63 to either deletion of
phenylalanine 64 (F64del), conversion of both serine 63 and thre-
onine 65 into phenylalanines (S63F/T65F), substitution of serine
63 with phenylalanine (S63F), or substitution of serine 63 with
cysteine (S63C), which alter the disposition of 3, 2, 1, or 0 hydro-
phobic residues, respectively. P0was fused at its carboxyl termi-
nus in framewith the discosoma red (DsRed) fluorescent protein.
Modification of P0 at the carboxyl terminus does not impair
targeting of P0 to the plasma membrane in cells (Shames
et al., 2003) or tomyelin in transgenic sciatic nerve (M.P., P. Fratta,
and L.W., unpublished data). The chimeras were transiently
expressed in COS-7 (Figure 3D) or Chinese hamster ovary
(CHO) cells (data not shown), and the cells were immunostained
for the ER resident lectin, calnexin (CNX) (Figure 3D). Both P0wt
and P0S63C were targeted to the plasma membrane, whereas
P0S63del was confined to the ER, consistent with prior analysis
of these mutant P0s in transgenic mice (Wrabetz et al., 2006). In
addition, transfected P0MycDsRed was trafficked to the cell
membrane (data not shown), just as P0Myc arrives to myelin in
transgenic sciatic nerve (Previtali et al., 2000), further validating
the transfected cells as a model. S63F was trafficked to the
cell membrane, whereas F64del and S63F/T65F were mostly
retained in the ER. Deletion of glutamic acid 71 in the loop con-
necting b strands C and C0 did not impair protein trafficking
(data not shown). S63del and F64del also induced BiP transcrip-
tion and XBP-1 splicing in COS-7 cells to levels similar to those
obtained upon tunicamycin treatment (Figure 3C). These data
suggest that it is not alteration of the side chain at residue 63
but rather a perturbed alignment of hydrophobic residues in
b strand C that results in ER retention and activation of the
UPR, providing further support for the notion that P0S63del is
globally misfolded.
UPR Is Dynamic and Reversible in Sciatic Nerve
S63del nerves are characterized by hypomyelination, demyeli-
nated fibers, and onion bulbs (Wrabetz et al., 2006). A few
nascent onion bulbs are detectable at postnatal day 28 (P28)
and become evident by 6 months of age. To determine whether
the UPR activation preceded or followed the appearance of
pathological findings in diseased nerves, we analyzed P0, BiP,
and CHOP expression across development. In WT and S63del-
L mice, BiP and CHOP mRNAs were immediately upregulated
during development, mirroring the robust induction of P0 expres-
sion that occurs immediately after birth and peaks around P28
(Figure 4), althoughCHOP rapidly leveled off andwasmaintained
at a plateau, suggesting more complicated regulation. Similar
results were obtained for S63del-H mice (data not shown).
Thus, the robust UPR asmeasured by peak BiP andCHOP levels
is associated with the onset of myelin instability, destruction, and
failed remyelination marked by onion bulbs.
The relative amounts of BiP and CHOP differed between
S63del-L and S63del-H mice (Figure 1). Given that BiP chaper-
one helps cells to fold aberrant proteins (Gething, 1999), whereas
CHOP may kill overwhelmed cells (Marciniak et al., 2004; Zinsz-
ner et al., 1998), the increased level of CHOP in the face of stable
amounts of BiP could represent a transition from a cell survivalresponse in S63del-L to an apoptotic reponse in S63del-H.
One prediction of this hypothesis would be that in S63del-L
nerves the level of BiP is near maximal and cannot be aug-
mented. Therefore, segments of sciatic nerves were explanted
and maintained in culture for 20 hr with or without tunicamycin.
At time zero, BiP and CHOP were increased by 3.3- and 3.8-
fold in S63del as compared to WT nerves (Figures 5A and 5B).
Surprisingly, 20 hr after axotomy, BiP and CHOP expression
decreased to levels similar to WT mice, although parallel treat-
ment with tunicamycin induced BiP/CHOP to 3.9/10.4- and
3.8/6.9-fold in WT and mutant mice, respectively. These data
indicate that, after axotomy, UPR is almost completely reversed
in mutant nerves and is reinduced to similar levels by tunica-
mycin. Unfortunately, additive effects cannot be addressed after
axotomy.
One possible explanation was that axotomy of the cultured
nerve segments produced acutely decreased mutant P0 (main-
tainence of Mpz expression depends on axonal signals; Trapp
et al., 1988). In fact, 20 hr after axotomy, the level of P0wt was
partially reduced (Figure 5C, arrow), whereas P0S63del was
Figure 4. Induction of the UPR Dynamically Parallels P0 Expression
P0 (A), BiP (B), or CHOP (C) mRNA levels in sciatic nerves were measured by
quantitative RT-PCR and normalized to 18S rRNA in WT (gray bars) or S63del
(black bars) mice. The level of P0 rises in both WT and S63del nerves at P7,
with a peak near P28. Only in S63del, not in WT nerves, BiP rises in parallel,
and CHOP rises by P7 to a plateau level that then persists. For P0 and BiP,
one representative experiment (animal) of three is shown; error bars, SEM;
n = 3. For CHOP, the average of seven experiments (animals) is shown
(anchored to P28wt and then expressed relative to P1wt = 1; error bars, SEM;
n = 7; **p < 0.05 relative to WT of the same age by Student’s t test).Neuron 57, 393–405, February 7, 2008 ª2008 Elsevier Inc. 397
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ble (Figure 5C, arrowhead). Similar results were obtained in sci-
atic nerve segments from S63del mice deleted of endogenous
P0, where only mutant P0 is present (S63del/). As expected,
this effect was transcriptionally mediated, as the level of P0
mRNA was very low at 20 hr after axotomy (Figure 5D), and
had fallen significantly already by 6 hr after axon cut (data not
shown). Thus, the UPR in S63del nerves is continuously acti-
vated by sustained expression of mutant protein. Transcriptional
induction of BiP and CHOP can be halted by simply discontinu-
ing mutant transgene expression, indicating that the UPR is
reversible in vivo.
Ablation of Chop Amelioriates Neuropathy
Of the UPR mediators, the level of CHOP expression correlated
best with disease severity. To demonstrate a direct role for the
CHOP-dependent arm of the UPR in the pathogenesis of demy-
elination in S63del nerves, we crossed S63del-L and Chop null
mice (Zinszner et al., 1998) and analyzed behavior, neurophysiol-
ogy, and morphology in WT, S63del, Chop null, and S63del/
Chop null littermates. Chop null mice show no overt neuromus-
cular defects (Zinszner et al., 1998; see below). Four-month-old
S63delmice had lost one-third to one-half of their motor capacity
as compared to WT or Chop null littermates in analysis by accel-
erating rotarod (Figure 6A) (Wrabetz et al., 2006). Strikingly,
S63del/Chop null mice regained completely normal motor ca-
pacity in rotarod analysis (Figure 6A). This was accompanied
by a partial rescue of electrophysiological and morphological
abnormalities. In particular, S63del mice manifest reduced nerve
Figure 5. Diminished P0S63del Levels Acutely Reverse Activation
of the UPR
Segments of WT or S63del-L sciatic nerves were snap-frozen either immedi-
ately after dissection (t = 0h, white bars) or after incubation ex vivo for 20 hr
with (t = 20h TUN, black bars) or without (t = 20h, gray bars) tunicamycin
and were analyzed for UPRmarkers. Levels of mRNAweremeasured by quan-
titative RT-PCR (A, B, and D) and normalized to PGK1 mRNA. BiP and CHOP
mRNAs are induced in S63del mice at t = 0h and remain induced with tunica-
mycin treatment for 20 hr after axotomy. Instead, induction is rapidly reversed
without tunicamycin, in parallel with marked reduction of the band containing
P0S63del by western analysis ([C], arrowhead), due to the general reduction of
P0 mRNA after axotomy (D). (S63del/) represents P0/ mice transgenic
for MpzS63del. b-Tubulin (Tub) is a control for protein loading. Error bars,
SEM, n = 3 animals.398 Neuron 57, 393–405, February 7, 2008 ª2008 Elsevier Inc.conduction velocity (NCV) and increased F-wave latency (Wra-
betz et al., 2006). In 6-month-old S63del/Chop null mice, the
F-wave latency was significantly improved, even if the NCV did
not change. In addition, there were half the number of demyeli-
nated fibers and a trend toward reduction of onion bulbs as com-
pared to S63del mice (Figure 6B and Table 1). Consistent with
unchanged NCV, hypomyelination remained (Figure 6B), as we
have documented previously in other transgenic mice that over-
express total P0 (Wrabetz et al., 2000). Finally, morphometric
analysis showed no change in the number or size distribution
of sciatic nerve axons (Figure S3). Thus, ablation of Chop res-
cued demyelination associated with toxic gain of function from
P0S63del.
Rescue was not due to reduced expression of theMpzS63del
transgene or reduced activation of the UPR. By RT-PCR analy-
sis, transgenic and endogenous Mpz mRNAs can be distin-
guished by exploiting a polymorphic restriction site (Wrabetz
et al., 2000). The amount of MpzS63del mRNA was about 50%
of the endogenous Mpz in both S63del and S63del/Chop null
mice at P28 and P180 (Figure 6C) (Wrabetz et al., 2006). Consis-
tent with the idea that P0S63del levels determine UPR activation,
BiP mRNA levels were similar in S63del and S63del/Chop null
nerves at P28 (Figure 6D) and remained induced 4- to 6-fold in
both at P42 and P120 (data not shown). Instead, Chop was un-
detectable as expected in S63del/Chop null nerve (Figure 6E).
Moreover, DOC1, which is induced in S63del-L nerve, was
reduced to basal levels in S63del/Chop null nerve (Figures 6F–
6H). Therefore, deletion of Chop from S63del mice restored
behavioral, electrophysiological, and morphological abnormali-
ties despite continued UPR, indicating that the CHOP arm of
the UPR is pathogenetic and suggesting that the expression of
Chop is a maladaptive response to P0S63del misfolding in
myelinating Schwann cells.
Chop Activation Is Associated with Delayed Apoptosis
in S63del Nerves
Prolonged ER stress and induced Chop expression can provoke
apoptosis (Oyadomari et al., 2002; Rutkowski et al., 2006; Zinsz-
ner et al., 1998). In fact, in S63del-L, the number of TUNEL-posi-
tive nuclei was 0.4% at P28 and 0.9%at P180, whereasWTmice
and Chop null mice showed very low levels of apoptosis. S63C,
P0-OE mice (dysmyelinating, not demyelinating neuropathies)
also showed no increase in apoptosis at P180 (Figure 7A). Abla-
tion of Chop in S63del mice decreased the number of TUNEL-
positive nuclei, indicating that CHOP causes apoptosis in
S63del nerves. Independently of UPR, demyelination itself also
provokes both proliferation and apoptosis in peripheral nerves
(Sancho et al., 2001). Therefore, to determine whether apoptosis
in S63del nerves was a direct consequence of CHOP signals or
secondary to demyelination, we analyzed its timing and whether
there was associated proliferation. Even if UPR activation as
measured by BiP and Chop expression peaked between P28
and P42, there were only slightly more TUNEL-positive nuclei
in S63del nerves at P42 as compared to P28, but many more
at 6 months old (Figure 7A). This pattern correlates instead
very closely to the trend of demyelination (Wrabetz et al.,
2006). In addition, in S63del nerves, apoptosis was not associ-
ated with cell loss, but with an increased number of cells,
Neuron
UPR Modulates CMT1B Neuropathyconsistent with supernumerary Schwann cells present in demy-
elination (Figure 7B). Indeed, cell death was compensated by in-
creased proliferation in S63del nerves at both P28 and P180,
typical of demyelination (Figure 7C). We also analyzed for pro-
teolytic cleavage of caspase-12, an event specific to UPR and
thought to be associated with cell death (Nakagawa et al.,
2000). The 42 kD activated caspase-12 was specifically enriched
in S63del nerves (Figure 7D, arrowhead) at P42 when the level of
apoptosis was relatively low. Moreover, at P28, ablation of Chop
Figure 6. Ablation of Chop Restores Motor Function
and Reduces Demyelination in S63del Mice
(A) Rotarod analysis of motor function showed that 4-month-
old S63del mice remain for 200 s less as compared to WT
and Chop null mice. Instead, S63del/Chop null mice perform
like WT mice. Error bars, SEM, n = 15–20 animals.
(B) Semithin sections stained with toluidine blue are shown
from P180 WT, S63del, Chop null, and S63del/Chop null sci-
atic nerves. S63del nerves manifest hypomyelination and de-
myelinated fibers and onion bulbs. Although hypomyelination
is not ameliorated in S63del/Chop null nerves, the number of
demyelinating fibers is significantly reduced (Table 1). Exam-
ples of pathological fibers from S63del or S63del/Chop null
nerves are shown magnified below. Arrows indicate demyeli-
nated fibers, stars indicate onion bulbs, and arrowheads indi-
cates remyelinating fibers. Scale bar, 15 mm in upper panels
and 5 mm in the magnified panels below.
(C) S63del transgene expression was analyzed in rescued
nerves by semiquantitative RT-PCR. Digestion of the am-
plimer with Dpn II distinguishes WT (326 bp) from transgenic
cDNA (244 and 82 bp fragments).
(D–H) BiP, CHOP, and DOC1, 6, and 4 expression was ana-
lyzed by quantitative RT-PCR and normalized to 18S rRNA.
Note that transgene expression and BiP activation remain in
S63del/Chop null nerves, whereas CHOP is undetectable
and DOC1 falls below WT levels. DOC6 and 4 are not induced
in S63del-L nerves. Error bars, SEM, n = 3.
and amelioration of demyelination reduced apopto-
sis to WT levels in S63del nerves, even if cleaved
caspase 12 remained easily detected (Figure 7D).
These data provide further evidence that activated
caspase 12 is not sufficient to cause cell death in
the context of UPR in tissues (Sharma and Gow,
2007). Thus, delayed cell death correlates best
with progressive demyelination, suggesting that
CHOP induces myelin instability and demyelin-
ation, which in turn causes, as a secondary consequence, prolif-
eration and cell death.
DISCUSSION
We describe a hereditary neuropathy associated with UPR. We
had previously shown that P0S63del produces demyelinating
neuropathy via a dose-dependent, toxic gain of function originat-
ing from the ER in transgenic Schwann cells (Wrabetz et al.,Table 1. Ablation of Chop Reduces Demyelination in S63del Sciatic Nerves
Electrophysiology Morphology
Genotype NCV (m/s) F-Wave Latency (ms) G Ratio % Onion Bulbs % Dem Fibers
wt 39 ± 1.1(15) 4.8 ± 0.22(15) 0.67 ± 0.028(6) 0 0
chop/ 38 ± 1.2(12) 4.8 ± 0.13(12) 0.70 ± 0.010(9) 0 0
S63del 32 ± 1.7(7) 6.1 ± 0.45(7) 0.76 ± 0.015(15) 0.45 ± 0.110(18) 0.82 ± 0.095(18)
S63del/chop/ 31 ± 0.9(10)ns 5.2 ± 0.15(10)* 0.74 ± 0.021(11)ns 0.35 ± 0.103(22)ns 0.45 ± 0.103(22)**
All values represent mean ± SEM(n); where n = number of animals, except for G ratio, where n = total microscopic fields from 3–5 animals; ns = not
significantly different, *p < 0.05 or **p < 0.01 relative to S63del by Student’s t test. NCV, nerve conduction velocity; G ratio is calculated as axonal
diameter/fiber diameter; % dem fibers, % demyelinated fibers.Neuron 57, 393–405, February 7, 2008 ª2008 Elsevier Inc. 399
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(A) TUNEL analysis in longitudinal sections of WT and mutant sciatic nerves at
P28 (gray bars), P42 (white bars), and P180 (black bars) reveals that cell death
is significantly increased in S63del nerves as compared to WT or other mutant
nerves. TUNEL-positive nuclei were usually elongated, suggesting that they
belonged to Schwann cells (data not shown). Ablation of Chop reduces cell
death to WT levels in S63del/Chop null nerves. Note that cell death in
S63del nerves at P180 is nearly double that of P28, whereas BiP and Chop ex-
pression peak at or before P28 (Figure 4). Error bars, SEM, for P28 and P180,
n = 27, 5, 14, 5, 6, or 6 animals in WT, Chop null, S63del, S63del/Chop null,
S63C, or OE (P0 wild-type overexpressor), respectively; for P42 WT and
S63del n = 3. *p < 0.001 by Student’s t test relative to WT or S63del/Chop null.
(B) Cell number per 403 field was estimated by counting DAPI-stained nuclei
in longitudinal sections of sciatic nerves. Chop ablation does not alter the nu-
clei/field in S63del nerves at either P28 or P180. *p < 0.002, &p < 0.05 by Stu-
dent’s t test relative toWT for n = 9–11 sections (2–3 sections from each of 3–5
animals).
(C) Cell proliferation was estimated by BrdU incorporation in P28 (gray bars)
and P180 (black bars) sciatic nerves from WT and mutant mice. Cell prolifera-
tion is increased in S63del mice at P28 and P180 and in S63del/Chop null mice
at P28. Error bars, SEM, n = 5, 3, 4, 3,WT,Chop null, S63del, S63del/Chop null,
respectively.
(D) Proteolytic cleavage of caspase-12 was analyzed by western analysis of
sciatic nerve lysates from P42 WT, S63del, S63C, and P0 OE or P28 WT,
Chop null, S63del, or S63del/Chop null animals. The amount of the 42 kD ac-
tivated form of caspase-12 (arrowhead) is strongly increased in S63del nerves
and remains after Chop ablation. A representative experiment (of three) is
shown. Numbers indicate Mr.400 Neuron 57, 393–405, February 7, 2008 ª2008 Elsevier Inc.2006). Here we show that P0S63del elicits a canonical UPR in
Schwann cells. Biochemical and mutation analyses suggest
that deletion of S63del alters the conformation of P0 b strand
C, leading to global misfolding and BiP binding to mutant P0.
As a consequence, Ire-1, Perk, and ATF6 pathways are acti-
vated, leading to Chop induction that parallels the severity of
neuropathy. Ablation of Chop from S63del mice restores motor
function and reduces demyelination, indicating that the CHOP
arm of the UPR is pathogenetic in S63del neuropathy. Themech-
anism, however, is surprising, for whereas cell death is reduced
in S63del/Chop null nerves, the neuropathy phenotype, the tim-
ing of cell death and the presence of proliferation indicate that
Chop primarily provokes demyelination and only secondarily
cell death. Thus, unlike in oligodendrocytes, where Chop is
part of the adaptive stress response and ameliorates cell death,
in Schwann cells Chop is part of a maladaptive stress response
and produces cell-specific dysfunction not primarily related to
cell death.
The UPR Is Specific to S63del Expression
The UPR has a physiological role in other cells that must coordi-
nately synthesize high levels of proteins and lipids (Ron andWal-
ter, 2007), and precisely coordinated gene dosage and protein
and lipid synthesis is pivotal for normal myelinogenesis (Saher
et al., 2005; Suter and Scherer, 2003; Wrabetz et al., 2004). Nev-
ertheless, neither the normal upregulation of myelin protein ex-
pression during myelinogenesis nor the overexpression of nor-
mal P0 or other mutant P0s (e.g., P0S63C, P0myc) nor the
expression of mutant PMP22Tr-J (Dickson et al., 2002) activated
the UPR to significant levels (there was a trend toward increased
levels of CHOPmRNA during myelin formation [Figure 4C]). Only
P0S63del, retained in the ER, activated UPR significantly.
Loss of b Strand C Periodicity Causes ER Retention
and Activation of the UPR
We show that ER retention of, and UPR activation by, P0S63del
was not due to the lack of S63 itself, but rather to alteration of
b strand C periodicity. S63 is the first residue of b strand C (Sha-
piro et al., 1996), characterized by an alternating pattern where
the hydrophobic side chains are oriented toward the protein
core and the hydrophilic side chains away. Therefore, deletion
of serine 63 might alter the orientation of the 4 hydrophobic res-
idues of b strand C, causing protein unfolding, as suggested by
the smear produced when S63del is resolved under nonreducing
conditions (Figure 3). Accordingly, deletion of F64, a CMT1B
mutation in human (Ikegami et al., 1996), was predicted to alter
disposition of 3 out of 4 hydrophobic residues. Indeed, F64del
was completely retained in theERandactivated theUPR in trans-
fected cells. Instead, S63F, also associated with a CMT1Bmuta-
tion in human (Blanquet-Grossard et al., 1995), did not alter traf-
ficking or induce a UPR in transfected cells. Clearly, the UPR is
only one of several ‘‘toxic’’ gain of function mechanisms associ-
ated withMpz-related neuropathies (Wrabetz et al., 2006).
The amino acid composition and disposition of P0 b strand
C residues are highly similar to the BiP binding domain in immu-
noglobulin (Gething, 1999). Under physiological conditions, BiP
binds UPR transducers IRE-1, PERK, and ATF6, maintaining
them inactive (Ron and Walter, 2007). Binding of accumulated
Neuron
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ATF6 processing. Therefore, we suggest that alteration
of P0S63del b strand C exposes a hydrophobic surface that
promotes BiP binding, thereby activating the UPR in S63del
Schwann cells.
UPR Directly Causes S63del CMT1B Neuropathy
CHOP expression correlated well with the level of MpzS63del
and disease severity, suggesting a direct role in the pathology.
Indeed, genetic ablation of Chop restored motor function. Sev-
eral observations support that ameliorated demyelination ac-
counts for the rescue. The number of demyelinated fibers was
reduced by half, and there was a trend toward reduced numbers
of onion bulbs, the hallmark of demyelination in neuropathy. The
F-wave latency—a neurophysiological measure of demyelin-
ation—returned to near normal. Finally, preterminal sprouting
at neuromuscular junctions, typical of demyelination, was res-
cued in S63del/Chop null mice (E.T., F. Court, and L.W., unpub-
lished data; Court et al., 2008).
However,Chop ablation did not rescue either hypomyelination
or reduced NCV. One possible explanation is that they are
caused by P0 overexpression—present in S63del nerves (Fig-
ure 4A) (Wrabetz et al., 2000). Alternatively, other UPR effectors
could alter differentiation (Acosta-Alvear et al., 2007; Tsang
et al., 2007) and cause hypomyelination. For example, sustained
activation of the MEK/ERK signaling pathway is associated with
UPR (Hu et al., 2004), and activated ERK kinases induce
Schwann cell de-differentiation (Harrisingh et al., 2004). In addi-
tion, ablation of Chop only rescued half of demyelination. The
UPR could also produce demyelination independently of
CHOP, as it broadly alters both the transcription and stability
of specific mRNAs (Hollien and Weissman, 2006; Ron and Wal-
ter, 2007) and has global effects on other metastable proteins
and their folding with consequential changes in function (Gidale-
vitz et al., 2006). PMP22 could be considered a metastable
protein (Pareek et al., 1997); alterations of PMP22 or its dosage
produce the most common hereditary demyelinating neuropa-
thy. These possibilities would all fit with a model of pathogenesis
where CHOP produces some demyelination, but other UPR me-
diators provoke further demyelination, as well as other aspects
of the neuropathy.
Although hypomyelination independent of CHOP signaling
may explain in part why ablation ofChop rescues rotarod perfor-
mance but not all of the electrophysiological and morphological
aspects of S63del neuropathy, other factors may intervene.
Rotarod performance is incompletely sensitive, and we analyzed
animals at 4–6 months of age, where demyelination is underway
but axonal damage is limited. In demyelinating neuropathy, dis-
ability correlates best with axonal damage, whereas how early
myelin alterations produce disability is largely unknown—neuro-
muscular junction alterations may play a role (Yin et al., 2004).
CHOP and Demyelination versus Cell Death
What role does cell death play in S63del pathogenesis? Under
conditions of persistent stress and prolonged activation, the
UPR initiates proapoptotic pathways (Rutkowski et al., 2006).
Accordingly, we observed an increased number of cells pro-
grammed to die in S63del mutant mice. Moreover, CHOP func-tions as a proapoptotic gene both when UPR is activated acutely
(Zinszner et al., 1998) and chronically (Oyadomari et al., 2002).
However, a series of observations in S63del nerves indicate
that UPR and CHOP induce demyelination with secondary cell
death and not vice versa. First, mouse models of neuropathy
due to death of Schwann cells manifest a different phenotype,
congenital hypomyelination (Messing et al., 1992). Instead,
S63del nerves show a classic ‘‘onion bulb’’ neuropathy, where
myelin is formed normally and then becomes unstable and is
destroyed. Second, the rise in TUNEL-positive nuclei is signifi-
cantly delayed relative to CHOP induction (compare Figures 7
and 4) and rises after demyelination is detected. Third, there is
accompanying proliferation and no decrease in cell numbers.
Demyelinating neuropathy from other causes typically manifests
cell death and proliferation at levels similar to S63del nerves
(Sancho et al., 2001). In contrast, the UPR has been implicated
in a number of misfolded protein disorders with primary cell
death, including diabetes (Oyadomari et al., 2002), GM1-gan-
gliosidosis (Tessitore et al., 2004), Pelizeaus-Merzbacher dis-
ease (Southwood et al., 2002), polyglutamine repeat diseases
(Nishitoh et al., 2002), and Alzheimer’s disease (Hoozemans
et al., 2005), where cell death is much more evident (typically
5%–20% as measured by percent pyknotic, tunel-, or caspase
3-positive nuclei; Knapp et al., 1986; McLaughlin et al., 2007;
Tessitore et al., 2004; versus less than 1% here). Finally, CHOP
is usually detected in nonpyknotic Schwann cell nuclei, associ-
ated with normal myelin sheaths (Figure 2), suggesting that
CHOP is associated with other early pathogenetic events, not
late cell death. This provides further support for the idea that
Chop induction in the context of UPR does not guarantee cell
death (Rutkowski et al., 2006).
One must be careful not to equate the effects of UPR and
CHOP; the UPR comprises a complex group of effectors. Does
UPR produce demyelination because the UPR is peculiar in
Schwann cells or because the UPR happens to occur in cells
that form myelin? We favor the latter. First, the UPR activation
is canonical, CHOP target genes are activated, and P0S63del
also activates a UPR in heterologous cells. Instead, the UPR,
or alterations to its mediators, perturb myelination by both oligo-
dendrocytes (Li et al., 2004; Lin et al., 2005; Richardson et al.,
2004; Southwood et al., 2002) and Schwann cells. In contrast,
the diverse effects of Chop ablation in the two cells indicate
opposing roles. CHOP is adaptive in oligodendrocytes of Rump-
shaker mice (Southwood et al., 2002), but maladaptive in
Schwann cells of S63del mice. A comparison of CHOP target
genes, as well as the relative level of activation of the arms
of the UPR, in the two pathological cells could illuminate the
differing response.
So how does the CHOP arm of the UPR perturb S63del
Schwann cells? It is important to note that the UPR and CHOP
are induced during myelin formation, but pathology appears
only later in mature myelin (de- not dys-myelination). Given that
hereditary demyelinating neuropathies are commonly associ-
ated with moderately altered protein dosage (Suter and Scherer,
2003;Wrabetz et al., 2004), an appealing hypothesis is thatChop
could target the program of myelin gene expression, perhaps via
its stoichiometry. This could occur either transcriptionally—
CHOP is a transcription factor that activates a downstreamNeuron 57, 393–405, February 7, 2008 ª2008 Elsevier Inc. 401
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1998)—or posttranscriptionally—CHOP target genes regulate
dephosphorylation of eIF2a and thereby stress-induced
changes in translation of specific mRNAs (Marciniak et al.,
2004). It is notable in this regard that subtle changes in transla-
tional control may exert dramatic effects on myelin homeostasis
in the CNS (Li et al., 2004; Richardson et al., 2004).
Activation of the UPR Occurs during Myelination
and Is Dynamic and Reversible
In S63del nerves, transcriptional induction of BiP and CHOP
begins within the first week of age during myelin formation.
The observation that the UPR is activated before appearance
of pathological symptoms strengthens the idea that the UPR
is pathogenetic in S63del nerves. Furthermore, activation of
the UPR was dynamically linked to continued expression of
MpzS63del. Indeed, when the Mpz mRNA disappeared after
axotomy, P0S63del disappeared quickly, and the UPR was
halted immediately. Given the capacity of Schwann cells to
remyelinate, this suggests that pathology could be reversed
in vivo. Likewise, disease reversibility in vivo has been reported
in other models of progressive neurodegenerative disorders as-
sociated with toxic mutant proteins, including Huntington’s dis-
ease (Yamamoto et al., 2000) and spinocerebellar ataxia type 1
(Zu et al., 2004).
Relevance to Neuropathies and Other Misfolded
Protein Diseases
One-third to one-half of hereditary neuropathies are due to amyr-
iad of small mutations in more than 20 genes (Suter and Scherer,
2003; Wrabetz et al., 2004). How can we develop unifying treat-
ment strategies? Common therapeutic targets will be key, and
alterations in protein trafficking and protein quality control
are common to many hereditary neuropathies. The UPR due to
S63del is pathogenetic, dose dependent, dynamic, and revers-
ible. But elimination of one UPR mediator, Chop, only rescues
half of demyelination—other aspects of UPR probably also con-
tribute to pathogenesis. These data provide a rationale for treat-
ment strategies aimed at eliminating directly the mutant protein,
thereby converting a more severe toxic neuropathy into a milder
neuropathy due to P0 haploinsufficiency. In this light, S63del
mice provide the opportunity for proof of principle, by allelic-spe-
cific RNAi, for example (Wood et al., 2007), that could ameliorate
diseases due to toxic protein quality control responses. Finally,
S63del mice provide an animal model where misfolded proteins
elicit a UPR, causing cellular dysfunction but not immediate
apoptosis. Mechanisms identified in this model may be relevant
to the first events of other misfolded protein diseases, such as
Alzheimer’s or Parkinson’s disease or diabetes.
EXPERIMENTAL PROCEDURES
Animals
All experiments involving animals were performed following experimental
protocols approved by the San Raffaele Scientific Institute Animal Care and
Use Committee. Transgenic mice expressing either P0 with serine 63deleted
(S63del) or substituted by cysteine (S63C) (Wrabetz et al., 2006), as well as
P0 overexpressor (OE), P0 null (Wrabetz et al., 2000), P0-Myc (Previtali
et al., 2000), or Chop null mice (Zinszner et al., 1998) have been previously402 Neuron 57, 393–405, February 7, 2008 ª2008 Elsevier Inc.described. All transgenic lines were maintained on the FVB/N background
(Charles River, Calco, Italy). Genotypes were determined as described in the
references above. Where indicated, mice were intraperitoneally injected with
1 mg tunicamycin/g body weight in 150 mM dextrose.
Western Analysis
Sciatic nerves from WT and transgenic mice were dissected, immediately fro-
zen in liquid nitrogen, and analyzed as previously described (Wrabetz et al.,
2000; see Supplemental Data for antibodies). Where indicated, sciatic nerves
were dissected, desheathed (to avoid the blood-nerve barrier), and incubated
with or without 10 mg/ml tunicamycin either overnight or 20 hr in DMEM, 10%
fetal calf serum, and 100 ng/ml nerve growth factor at 37C in 5% CO2 humid-
ified atmosphere. Samples were then frozen in liquid nitrogen and processed.
To analyze disulfide bond formation, sample buffer lacked 2-mercaptoethanol
and either contained or lacked 200 mM dithiothreitol (DTT). Before loading,
samples were incubated 10 min at room temperature with 0.1 M iodoaceta-
mide. All westerns were repeated at least three times with similar results.
Semiquantitative Reverse-Transcription Polymerase
Chain Reaction Analysis
Sciatic nerves from WT and transgenic mice were immediately frozen in liquid
nitrogen after dissection. Total RNA was prepared with Trizol (Roche Diagnos-
tic GmbH, Germany), and 400 ng of RNAwere reverse transcribed using 1 mM
dNTPs, 2.5 ng/ml random examers, 40 units RNasin, and 20 units AMVReverse
Transcriptase (Promega, WI, USA). Samples were incubated 10 min at room
temperature and 1 hr at 42C. The same volume of RT products was used to
amplify glyceraldehyde-3-phosphate dehydrogenase (GAPDH), X-box binding
protein (XBP-1) and P0. Digestion of the P0 amplimer for a DpnII polymorphism
distinguished WT FVB/N alleles from BALB/C transgenic allele (Wrabetz et al.,
2000).
Taqman Quantitative PCR Analysis
Quantitative PCR was performed according to the manufacturer’s instructions
(Taqman, PE Applied Biosystems Instruments) on an ABI PRISM 7700 se-
quence detection system (Applied Biosystems Instruments). The relative stan-
dard curve method was applied using WT mice as reference. Normalization
was performed using either 18S rRNA or phosphoglycerate 1 (PGK1) as refer-
ence genes. Target and reference gene PCR amplification were performed in
separate tubes with Assays on Demand (Applied Biosystems Instruments, see
Supplemental Data for assay numbers). Total RNAwas prepared as described
above from normal and mutant mice. To measure BiP and P0, 400 ng of RNA
were retrotranscribed as described above. For the other genes, 4 mg of total
RNA were retrotranscribed using the SuperScriptII RNase H Reverse Tran-
scriptase (Invitrogen, USA) as per the manufacturer’s instructions.
DNA Constructs
A rat cDNA containing the P0 open reading frame (the kind gift of Marie Filbin,
Hunter College, NY, USA) was cloned into the pBlue-Script vector (Stratagene,
La Jolla, CA). The cDNA was amplified by polymerase chain reaction (PCR)
with the following oligonucleotides: forward 50-GGGGAAGCTTATGGCTCCTG
GGGCTCC, reverse 50-GGGGGATCCCGTTTCTTATCCTTGCGAGACTC, con-
tainingHindIII andBamHI restriction sites (underlined). The reverse primer does
not include the stop codon. The HindIII-BamHI fragment was cloned in frame
into the corresponding sites of the pDsRed-N1 (Clontech, Palo Alto, CA), gen-
erating the pP0-Red vector. Site-directed mutagenesis was performed via the
QuikChange Site-Direct Mutagenesis Kit (Stratagene, La Jolla, USA) as per the
manufacturer’s instructions, using as template the pP0-Red plasmid (see
Supplemental Data for oligonucleotides). All amplimers were confirmed by
automated sequence analysis.
Cell Transfection
COS-7 or CHOcells were transfected using a standard calciumphosphate pre-
cipitation protocol (Taveggia et al., 1998). Forty-eight hours later, the propor-
tion of live transfected cells was determined as a measure of transfection effi-
ciency. Thereafter, total RNA was extracted, and 400 ng of total RNA were
retrotranscribed as described above. BiP mRNA and 18S rRNA levels were
measured by Taqman analysis. The BiP/18S ratio (B) was normalized for
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activation with the weighting calculation: B = [(X3T) + (C3 (1 T))]/[(D3 R) +
(C3 (1R))], where X is the value of BiP/18S induced by the P0mutant, T is the
fraction of cells transfected with P0mutantDsRed fusion, C represents the
endogenous BiP/18S in untransfected cells arbitrarily set to 1, D is the level
of BiP/18S from cells transfected with the sham vector pDsRed, and R is frac-
tion of cells transfected with pDsRed. XBP-1 was analyzed via RT-PCR. Equal
amounts of RT products were used to amplify GAPDH and XBP-1. Where
indicated, cells were treated for 12 hr with 1 mg/ml tunicamycin at 37C in
5% CO2 humidified atmosphere. In this case, T was considered as 1. Parallel
transfections performed with P0mutant-monoDsRed (nondimerizing) con-
structs reproduced the intracellular localization and XBP-1 splice results
(data not shown).
Immunofluorescence Analysis
Immunofluorescence was performed on cells, sciatic nerves, or teased fibers
from sciatic nerves as previously described (Occhi et al., 2005; Pennuto
et al., 2003; Wrabetz et al., 2006; see Supplemental Data for details and
antibodies).
Behavioral, Morphological, and Electrophysiological Analysis
Motor ability was assessed in 4-month-old mice by rotarod analysis, as previ-
ously described (Wrabetz et al., 2006). The number of demyelinated axons and
onion bulbs were counted blind to genotype in semithin sections stained with
toluidine blue in images acquired with a 1003 objective as described (Quattrini
et al., 1996). We analyzed 3500–5000 fibers in 22–40 fields for each genotype
in 15 WT, 11 chop null, 18 S63del, and 22 S63del-chop null animals. One of us
(A.Q.) was able to distinguish all of the P0S63del from P0S63del/chop null
nerves when blinded to genotype. Semiautomated computer-based mor-
phometry was performed on semithin sections of sciatic nerve to determine
the G ratio and the distribution of fiber diameters for myelinated axons as
described (Bolis et al., 2005). Six to fifteen microscopic fields from nerves of
three to five animals per genotype were analyzed. Electron microscopy was
performed as described (Quattrini et al., 1996). Electrophysiology was
performed as previously described (Bolino et al., 2004).
Bromodeoxyuridine Incorporation and Terminal Deoxynucleotidyl
Transferase-Mediated dUTP-Biotin Nick End Labeling Analysis
WT and transgenic mice were intraperitoneally injected with 100 mg/g body
weight of a 150 mM NaCl solution containing 10 mg/ml BrdU. One hour later,
mice were sacrificed and sciatic nerves were embedded in OCT (Miles) and
snap frozen in liquid nitrogen. Longitudinal 8 mm cryosections were fixed in
cold methanol for 20 min at –20C, washed in PBS, and incubated 25 min in
2 N HCl. After washing in PBS, specimens were incubated 10 min in 0.1 M
Na2B4O7 (pH 8.5) and 10 min in PBS. Blocking was performed for 30 min in
10% goat serum in PBS. Incubation with primary monoclonal anti-BrdU anti-
body 1:20 (Roche, Switzerland) and secondary goat anti-mouse-FITC 1:50
(Southern Biotech, Birmingham, AL, USA) together with Hoechst 1:1000 was
performed in 0.1% bovine serum albumin and 0.1% Triton in PBS. Specimens
were then rinsed in 1% BSA and 0.2% Triton in PBS and mounted as
described above. TUNEL analysis was performed as previously described
(Feltri et al., 2002).
Supplemental Data
The Supplemental Data for this article can be found online at http://www.
neuron.org/cgi/content/full/57/3/393/DC1/.
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